Valneva Se Adr Stock Today

VALN Stock  USD 7.75  0.25  3.12%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 66

 
High
 
Low
Quite High
Valneva SE is selling at 7.75 as of the 17th of April 2024; that is -3.12 percent decrease since the beginning of the trading day. The stock's open price was 8.0. Valneva SE has more than 66 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Valneva SE ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 18th of March 2024 and ending today, the 17th of April 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
5th of May 2021
Category
Healthcare
Classification
Health Care
Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. The company was founded in 1998 and is headquartered in Saint-Herblain, France. Valneva Se is traded on NASDAQ Exchange in the United States.. The company has 69.58 M outstanding shares of which 47.49 K shares are at this time shorted by private and institutional investors with about 2.92 trading days to cover. More on Valneva SE ADR

Moving against Valneva Stock

  0.71VXRT Vaxart Inc Financial Report 2nd of May 2024 PairCorr
  0.67CRL Charles River Labora Financial Report 9th of May 2024 PairCorr
  0.61NVO Novo Nordisk AS Financial Report 2nd of May 2024 PairCorr
  0.53GRTX Galera Therapeutics Financial Report 9th of May 2024 PairCorr
  0.45EVGN Evogene Financial Report 16th of May 2024 PairCorr
  0.45EWTX Edgewise Therapeutics Downward RallyPairCorr

Valneva Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Valneva SE's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Valneva SE or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO PresidentThomas Lingelbach
Thematic Ideas
Showing 3 out of 6 themes
Old NameValora Holding
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Management, Management, Computers, IT, Biotech, Pharmaceutical Products, Health Care, Biotechnology, Biotechnology, Healthcare, Computing (View all Sectors)
Average Analyst Recommendation
Analysts covering Valneva SE report their recommendations after researching Valneva SE's financial statements, talking to executives and customers, or listening in on Valneva SE's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Valneva SE ADR. The Valneva consensus assessment is calculated by taking the average forecast from all of the analysts covering Valneva SE.
Valneva SE's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Valneva SE's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Valneva SE's financial leverage. It provides some insight into what part of Valneva SE's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Valneva SE's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Valneva SE deploys its capital and how much of that capital is borrowed.
Liquidity
Valneva SE cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 208.82 M in liabilities with Debt to Equity (D/E) ratio of 1.43, which is about average as compared to similar companies. Valneva SE ADR has a current ratio of 1.13, suggesting that it may not have the ability to pay its financial obligations when due. Debt can assist Valneva SE until it has trouble settling it off, either with new capital or with free cash flow. So, Valneva SE's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Valneva SE ADR sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Valneva to invest in growth at high rates of return. When we think about Valneva SE's use of debt, we should always consider it together with cash and equity.

Other Non Cash Items

11.28 Million
Valneva SE ADR (VALN) is traded on NASDAQ Exchange in USA and employs 676 people. Valneva SE is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 595.01 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Valneva SE's market, we take the total number of its shares issued and multiply it by Valneva SE's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Valneva SE ADR conducts business under Biotechnology sector and is part of Health Care industry. The entity has 69.58 M outstanding shares of which 47.49 K shares are at this time shorted by private and institutional investors with about 2.92 trading days to cover. Valneva SE ADR currently holds about 336.22 M in cash with (214.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.74.
Check Valneva SE Probability Of Bankruptcy
Ownership Allocation
Valneva SE ADR shows a total of 69.58 Million outstanding shares. About 99.0 % of Valneva SE outstanding shares are held by general public with 0.6 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Valneva Ownership Details

Valneva Stock Price Odds Analysis

Contingent on a normal probability distribution, the odds of Valneva SE jumping above the current price in 90 days from now is about 60.32%. The Valneva SE ADR probability density function shows the probability of Valneva SE stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.1375. This entails Valneva SE ADR market returns are highly reactive to returns on the market. As the market goes up or down, Valneva SE is expected to follow. Additionally, valneva SE ADR has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 7.75HorizonTargetOdds Above 7.75
39.52%90 days
 7.75 
60.32%
Based on a normal probability distribution, the odds of Valneva SE to move above the current price in 90 days from now is about 60.32 (This Valneva SE ADR probability density function shows the probability of Valneva Stock to fall within a particular range of prices over 90 days) .

Valneva Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Valneva SE that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Valneva SE's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Valneva SE's value.
InstituionRecorded OnShares
General American Investors Company Inc2023-12-31
345 K
Ubs Group Ag2023-09-30
0.0
Alphacentric Advisors, Llc2023-12-31
34.3 K
Laurion Capital Management Lp2023-09-30
25 K
Morgan Stanley - Brokerage Accounts2023-12-31
4.4 K
Wells Fargo & Co2023-12-31
2.5 K
Barclays Plc2023-12-31
417
Advisor Group Holdings, Inc.2023-12-31
150
Qube Research & Technologies2023-12-31
22.0
Royal Bank Of Canada2023-12-31
20.0
Ridgewood Investments Llc2023-09-30
0.0
View Valneva SE Diagnostics

Valneva SE Historical Income Statement

Valneva SE ADR Income Statement is one of the three primary financial statements used for reporting Valneva's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Valneva SE ADR revenue and expense. Valneva SE Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Valneva SE's Depreciation And Amortization is very stable compared to the past year. As of the 17th of April 2024, Interest Expense is likely to grow to about 24.5 M, while Total Revenue is likely to drop about 92.2 M. View More Fundamentals

Valneva Stock Against Markets

Picking the right benchmark for Valneva SE stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Valneva SE stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Valneva SE is critical whether you are bullish or bearish towards Valneva SE ADR at a given time. Please also check how Valneva SE's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Valneva SE without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Volatility Now

   

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Module

Valneva SE Corporate Management

Elected by the shareholders, the Valneva SE's board of directors comprises two types of representatives: Valneva SE inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Valneva. The board's role is to monitor Valneva SE's management team and ensure that shareholders' interests are well served. Valneva SE's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Valneva SE's outside directors are responsible for providing unbiased perspectives on the board's policies.

How to buy Valneva Stock?

Before investing in Valneva SE, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Valneva SE. To buy Valneva SE stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Valneva SE. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Valneva SE stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Valneva SE ADR stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Valneva SE ADR stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Valneva SE ADR, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Valneva Stock please use our How to Invest in Valneva SE guide.

Already Invested in Valneva SE ADR?

The danger of trading Valneva SE ADR is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Valneva SE is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Valneva SE. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Valneva SE ADR is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Valneva SE ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Valneva SE's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Valneva Se Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Valneva Se Adr Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Valneva SE ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Valneva Stock analysis

When running Valneva SE's price analysis, check to measure Valneva SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Valneva SE is operating at the current time. Most of Valneva SE's value examination focuses on studying past and present price action to predict the probability of Valneva SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Valneva SE's price. Additionally, you may evaluate how the addition of Valneva SE to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Is Valneva SE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Valneva SE. If investors know Valneva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Valneva SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.55)
Revenue Per Share
2.218
Quarterly Revenue Growth
(0.79)
Return On Assets
(0.10)
Return On Equity
(0.58)
The market value of Valneva SE ADR is measured differently than its book value, which is the value of Valneva that is recorded on the company's balance sheet. Investors also form their own opinion of Valneva SE's value that differs from its market value or its book value, called intrinsic value, which is Valneva SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Valneva SE's market value can be influenced by many factors that don't directly affect Valneva SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Valneva SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Valneva SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Valneva SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.